QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(State or other jurisdiction of Incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Large accelerated filer
|
☐
|
|
☑
|
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
|
Emerging growth company
|
|
Page No.
|
|||
PART I—FINANCIAL INFORMATION
|
|||
ITEM 1
|
Financial Statements (Unaudited)
|
||
6
|
|||
7
|
|||
Consolidated Statements of Income for the six months ended June 30, 2023 and 2022 | 8 |
||
9
|
|||
Consolidated Statements of Comprehensive Income for the six months ended June 30, 2023 and 2022 |
9 |
||
10
|
|||
11
|
|||
11 |
|||
12
|
|||
ITEM 2
|
35
|
||
ITEM 3
|
46 | ||
ITEM 4
|
46 | ||
PART II—OTHER INFORMATION
|
|||
ITEM 1
|
47 |
||
ITEM 1A
|
47 |
||
ITEM 2
|
48 | ||
ITEM 3
|
48 | ||
ITEM 4
|
48 | ||
ITEM 5
|
48 | ||
ITEM 6
|
49 |
||
50 |
● |
declining sales of tobacco
products, and expected continuing decline of sales, in the tobacco industry overall;
|
● |
our dependence on a small number
of third-party suppliers and producers;
|
● |
the possibility that we will be
unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost;
|
● |
the possibility that our
licenses to use certain brands or trademarks will be terminated, challenged or restricted;
|
● |
failure to maintain consumer
brand recognition and loyalty of our customers;
|
● |
our reliance on relationships
with several large retailers and national chains for distribution of our products;
|
● |
intense competition and our
ability to compete effectively;
|
● |
competition from illicit sources
and the damage caused by illicit products to brand equity;
|
● |
contamination of our tobacco
supply or products;
|
● |
uncertainty and continued evolution of the markets for our Creative Distribution Solutions products;
|
● |
complications with the design or
implementation of our new enterprise resource planning system could adversely impact our business and operations;
|
● |
substantial and increasing U.S.
regulation;
|
● |
regulation or marketing denials of our products by the U.S. Food and Drug Administration, which has broad regulatory powers;
|
● |
many of our products contain
nicotine, which is considered to be a highly addictive substance;
|
● |
requirement to maintain compliance with master settlement agreement escrow
account;
|
● |
possible significant increases
in federal, state and local municipal tobacco- and vapor-related taxes;
|
● |
our products are subject to
developing and unpredictable regulation, such as court actions that impact obligations;
|
● |
increase in state and local regulation of our Creative Distribution Solutions products has been proposed or enacted;
|
● |
increase in tax of our Creative Distribution Solutions products could adversely affect our business;
|
● |
sensitivity of end-customers to
increased sales taxes and economic conditions including significant increases in the rate of inflation and other declines in purchasing power;
|
● |
uncertainty surrounding FDA compliance policy;
|
● |
possible increasing
international control and regulation;
|
● |
failure to comply with
environmental, health and safety regulations;
|
● |
imposition of significant tariffs on imports into the U.S.;
|
● |
the scientific community’s lack
of information regarding the long-term health effects of certain substances contained in some of our products;
|
● |
significant product liability
litigation;
|
● |
our amount of indebtedness;
|
● |
the terms of our indebtedness,
which may restrict our current and future operations;
|
● |
our ability to comply with required disclosure requirements;
|
● |
identification of material weaknesses in our internal control over financial reporting, which, if not remediated appropriately or timely, could result in loss of investor confidence
and adversely impact our stock price;
|
● |
our certificate of incorporation and
bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition bids or merger proposals, which may adversely affect the market price of our common stock;
|
● |
our certificate of incorporation limits the ownership of
our common stock by individuals and entities that are Restricted Investors. These restrictions may affect the liquidity of our common stock and may result in Restricted Investors (as defined in our Certificate of Incorporation) being
required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution rights;
|
● |
future sales of our common stock
in the public market could reduce our stock price, and any additional capital raised by us through the sale of equity or convertible securities may dilute your ownership in us;
|
● |
we may issue preferred stock
whose terms could adversely affect the voting power or value of our common stock;
|
● |
our business may be damaged by
events outside of our suppliers’ control, such as the impact of epidemics (e.g., coronavirus), political upheavals, or natural disasters;
|
● |
adverse impact of climate change;
|
● |
our reliance on information technology;
|
● |
cybersecurity and privacy
breaches;
|
● |
failure to manage our growth;
|
● |
failure to successfully
integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;
|
● |
fluctuations in our results;
|
● |
exchange rate fluctuations;
|
● |
adverse U.S. and global economic
conditions;
|
● |
departure of key management
personnel or our inability to attract and retain talent;
|
● |
infringement on or
misappropriation of our intellectual property;
|
● |
third-party claims that we
infringe on their intellectual property; and
|
● |
failure to meet expectations relating to environmental, social and
governance factors.
|
(unaudited)
|
||||||||
June 30, | December 31, | |||||||
ASSETS
|
2023
|
2022
|
||||||
Current assets:
|
||||||||
Cash
|
$
|
|
$
|
|
||||
Accounts receivable, net of allowances of $
|
|
|
||||||
Inventories
|
|
|
||||||
Other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
Property, plant, and equipment, net
|
|
|
||||||
Deferred income taxes
|
|
|
||||||
Right of use assets
|
|
|
||||||
Deferred financing costs, net
|
|
|
||||||
Goodwill
|
|
|
||||||
Other intangible assets, net
|
|
|
||||||
Master Settlement Agreement (MSA) escrow deposits
|
|
|
||||||
Other assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
|
$
|
|
||||
Accrued liabilities
|
|
|
||||||
Other current liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Notes payable and long-term debt
|
|
|
||||||
Lease liabilities
|
|
|
||||||
Total liabilities
|
|
|
||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity:
|
||||||||
Preferred stock; $
|
|
|
||||||
Common stock, voting, $
|
|
|
||||||
Common stock, nonvoting, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Cost of repurchased common stock (
|
(
|
)
|
(
|
)
|
||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Accumulated earnings
|
|
|
||||||
Non-controlling interest
|
|
|
||||||
Total stockholders’ equity
|
|
|
||||||
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
Three Months Ended
June 30,
|
||||||||
2023
|
2022
|
|||||||
Net sales
|
$
|
|
$
|
|
||||
Cost of sales
|
|
|
||||||
Gross profit
|
|
|
||||||
Selling, general, and administrative expenses
|
|
|
||||||
Operating income
|
|
|
||||||
Interest expense, net
|
|
|
||||||
Investment loss
|
|
|
||||||
Gain on extinguishment of debt
|
( |
) | ||||||
Income before income taxes
|
|
|
||||||
Income tax expense
|
|
|
||||||
Consolidated net income
|
|
|
||||||
Net loss attributable to non-controlling interest
|
(
|
)
|
(
|
)
|
||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
||||
Basic income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
||||
Diluted income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
||||
Weighted average common shares outstanding:
|
||||||||
Basic
|
|
|
||||||
Diluted
|
|
|
Six Months
Ended
June 30,
|
||||||||
2023
|
2022
|
|||||||
Net sales
|
$
|
|
$
|
|
||||
Cost of sales
|
|
|
||||||
Gross profit
|
|
|
||||||
Selling, general, and administrative expenses
|
|
|
||||||
Operating income
|
|
|
||||||
Interest expense, net
|
|
|
||||||
Investment loss
|
|
|
||||||
Gain on extinguishment of debt
|
(
|
)
|
|
|||||
Income before income taxes
|
|
|
||||||
Income tax expense
|
|
|
||||||
Consolidated net income
|
|
|
||||||
Net loss attributable to non-controlling interest
|
(
|
)
|
(
|
)
|
||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
||||
Basic income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
||||
Diluted income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
||||
Weighted average common shares outstanding:
|
||||||||
Basic
|
|
|
||||||
Diluted
|
|
|
Three Months Ended
June 30,
|
||||||||
2023
|
2022
|
|||||||
Consolidated net income
|
$
|
|
$
|
|
||||
Other comprehensive income (loss), net of tax
|
||||||||
Unrealized loss on MSA investments, net of tax of $
|
(
|
)
|
(
|
)
|
||||
Foreign currency translation, net
of tax of $
|
(
|
)
|
|
|||||
Unrealized loss on derivative instruments, net of tax of $
|
(
|
)
|
|
|||||
(
|
)
|
(
|
)
|
|||||
Consolidated comprehensive income
|
|
|
||||||
Comprehensive loss attributable to non-controlling interest
|
(
|
)
|
(
|
)
|
||||
Comprehensive income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
Six
Months Ended
June 30,
|
||||||||
2023
|
2022
|
|||||||
Consolidated net income
|
$
|
|
$
|
|
||||
Other comprehensive income (loss), net of tax
|
||||||||
Unrealized gain (loss) on
MSA investments, net of tax of $
|
|
(
|
)
|
|||||
Foreign currency translation, net
of tax of $
|
(
|
)
|
|
|||||
Unrealized loss on
derivative instruments, net of tax of $
|
(
|
)
|
|
|||||
(
|
)
|
(
|
)
|
|||||
Consolidated comprehensive income
|
|
|
||||||
Comprehensive loss attributable to non-controlling interest
|
(
|
)
|
(
|
)
|
||||
Comprehensive income attributable to Turning Point Brands, Inc.
|
$
|
|
$
|
|
Six
Months Ended
June 30,
|
||||||||
2023
|
2022
|
|||||||
Cash flows from operating activities:
|
||||||||
Consolidated net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Gain on extinguishment of debt
|
(
|
)
|
|
|||||
Loss (gain) on sale of property, plant, and equipment
|
|
(
|
)
|
|||||
Depreciation expense
|
|
|
||||||
Amortization of other intangible assets
|
|
|
||||||
Amortization of deferred financing costs
|
|
|
||||||
Deferred income tax expense (benefit)
|
|
(
|
)
|
|||||
Stock compensation expense
|
|
|
||||||
Noncash lease income
|
(
|
)
|
(
|
)
|
||||
Loss on investments
|
|
|
||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
|
(
|
)
|
|||||
Inventories
|
(
|
)
|
(
|
)
|
||||
Other current assets
|
|
(
|
)
|
|||||
Other assets
|
(
|
)
|
|
|||||
Accounts payable
|
|
|
||||||
Accrued liabilities and other
|
(
|
)
|
|
|||||
Net cash provided by operating activities
|
$
|
|
$
|
|
||||
Cash flows from investing activities:
|
||||||||
Capital expenditures
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Restricted cash, MSA escrow deposits
|
$
|
|
$
|
(
|
)
|
|||
Proceeds on the sale of property, plant and equipment
|
|
|
||||||
Net cash used in investing activities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Cash flows from financing activities:
|
||||||||
Convertible Senior Notes repurchased
|
$ | ( |
) | $ | ||||
Proceeds from call options
|
||||||||
Payment of dividends
|
(
|
)
|
(
|
)
|
||||
Exercise of options
|
|
|
||||||
Redemption of options
|
( |
) | ( |
) | ||||
Redemption of performance restricted stock units
|
( |
) | ( |
) | ||||
Common stock repurchased
|
|
(
|
)
|
|||||
Net cash used in financing activities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Net decrease in cash
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Effect of foreign currency translation on cash
|
$
|
(
|
)
|
$
|
|
|||
Cash, beginning of period:
|
||||||||
Unrestricted
|
|
|
||||||
Restricted
|
|
|
||||||
Total cash at beginning of period
|
|
|
||||||
Cash, end of period:
|
||||||||
Unrestricted
|
|
|
||||||
Restricted
|
|
|
||||||
Total cash at end of period
|
$
|
|
$
|
|
||||
Supplemental schedule of noncash investing activities:
|
||||||||
Accrued capital expenditures
|
$
|
|
$
|
|
||||
Supplemental schedule of noncash financing activities:
|
||||||||
Dividends declared not paid
|
$
|
|
$
|
|
Accumulated | ||||||||||||||||||||||||||||||||
Common | Additional | Cost of |
Other | Non- | ||||||||||||||||||||||||||||
Voting | Stock, | Paid-In | Repurchased |
Comprehensive | Accumulated | Controlling | ||||||||||||||||||||||||||
Shares
|
Voting
|
Capital
|
Common Stock
|
Income (Loss)
|
Earnings
|
Interest
|
Total
|
|||||||||||||||||||||||||
Beginning balance April 1, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||||||||
Unrealized loss on MSA investments, net of tax of $
|
-
|
|
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||||||
Unrealized loss on derivative instruments, net of tax of $ |
- | ( |
) | ( |
) | |||||||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
-
|
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||||
Stock compensation expense
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Exercise of options
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Redemption of options
|
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Performance restricted stock units issuance
|
||||||||||||||||||||||||||||||||
Performance restricted stock units redeemed
|
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Settlement of call options, net of tax of $
|
- | |||||||||||||||||||||||||||||||
Dividends
|
-
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||||||||
Ending balance June 30, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||||||||
Beginning balance April 1, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||||||||
Unrealized loss on MSA investments, net of tax of $
|
- | ( |
) | ( |
) | |||||||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
- | |||||||||||||||||||||||||||||||
Stock compensation expense
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Exercise of options
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Redemption of options
|
( |
) | ( |
) | ||||||||||||||||||||||||||||
Performance restricted stock units issuance
|
||||||||||||||||||||||||||||||||
Performance restricted stock units redeemed
|
( |
) | ( |
) | ||||||||||||||||||||||||||||
Cost of repurchased common stock
|
(
|
)
|
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||||
Dividends
|
-
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||||||||
Ending balance June 30, 2022
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
Accumulated | ||||||||||||||||||||||||||||||||
Common | Additional |
Cost of |
Other | Non- | ||||||||||||||||||||||||||||
Voting | Stock, | Paid-In | Repurchased |
Comprehensive | Accumulated | Controlling | ||||||||||||||||||||||||||
Shares
|
Voting
|
Capital
|
Common Stock
|
Income (Loss)
|
Earnings
|
Interest
|
Total
|
|||||||||||||||||||||||||
Beginning balance January 1, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||||||||
Unrealized gain on MSA investments, net of tax of $
|
-
|
|
|
|
|
|||||||||||||||||||||||||||
Unrealized loss on derivative instruments, net of tax of $ |
- | ( |
) | ( |
) | |||||||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
-
|
|
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||||
Stock compensation expense
|
-
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Exercise of options
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Redemption of options
|
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Performance restricted stock units issuance
|
|
|||||||||||||||||||||||||||||||
Performance restricted stock units redeemed
|
( |
) | ( |
) |